RE: BREAKOUT TIME- HEADING TOWARDS 15p18 Sep 2025 17:20
Have mgt ever provided an update on NHS usage? Bonkers to think that the NHS isn;t the biggest customer of a cutting-edge UK biotech company that can improve the lives of millions of Brits, and save the country tens of billions in healthcare costs. Instead they have the US as their biggest market. Says everything you need to know about the UK and NHS system.
Crazy to think a company that is about to go through the hockey stick adoption rate, with all major US approvals in place, and has spent $100m in R&D and approval costs, is worth less than USD$35m. I'm pretty heavily loaded with 825k shares but if it drops back to the 7's then I'll go in for more. If this cannot make me money, then I don't know what will. Take-over rumours last year sent the company to 40p. Obviously more shares in issue now, but that's still 3x current sp, and the company has a very healthy cash runway. Just needs another piece of good news.
Would be grateful if anyone has anything to share on NHS adoption.